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Brugada syndrome (BrS) is a rare inherited condition in which ventricular ar-rhythmias may cause syncope, aborted cardiac arrest, or sudden cardiac death. Although BrS is associated with mutations in the SCN5A gene, most 
adult patients are SCN5A-mutation negative.1 Fever can unmask the diagnostic 
Brugada type-1 pattern on the ECG2 and precede arrhythmic symptoms, especially 
in children.3 All children considered at risk for BrS, based on a family history of BrS 
or a BrS genotype are currently advised to record an ECG during fever (≥38.5°C/1
01.3°Fahrenheit) for diagnosis and risk stratification. This is stressful and time con-
suming for both patients and parents. We hypothesized that a type-1 fever-ECG 
and symptoms only occur in children with a familial SCN5A mutation.
One hundred eleven pediatric patients aged <19 years were eligible because 
they had ≥1 fever-ECG recorded and were at-risk for BrS, by having a BrS geno-
type, a first-degree family member with BrS, or a first-degree family member 
with a BrS genotype. After exclusion of probands, carriers of overlap syndrome 
mutations or multiple SCN5A variants, and those with structural cardiac abnor-
malities, 97 children were included. Fever-ECGs and nonfever-ECGs recorded 
during outpatient visits closest to the date of the fever-ECGs were analyzed for 
a type-1 pattern by a blinded expert (A.A.M.W.) and patient characteristics were 
collected. Patients with ≥1 type-1 fever-ECG during follow-up were compared 
with those without. Categorical variables were compared using a χ2 test or Fisher 
exact test, and Bonferroni correction for multiple comparisons was applied where 
appropriate. Continuous variables were compared using a Wilcoxon rank-sum 
test for not-normal distributions. The study was approved by the Institutional 
Review Board. Informed consent was waived because the study used retrospec-
tive data from regular care.
A total of 309 ECGs from 97 patients were analyzed (193 fever-ECGs and 116 
nonfever-ECGs). A type-1 pattern was seen on 22 (11.4%) fever-ECGs from 14 dif-
ferent patients and on none of the nonfever-ECGs. The median age at first episode 
of a fever-induced type-1 was 7.1 (2.8–10.6) years. In 7 patients the type-1 pattern 
was not apparent on the first recorded fever-ECG, but on a subsequent fever-ECG 
recorded after a median of 0.7 (0.1–4.9) years. A positive family history for sudden 
cardiac death, sex, first-degree family member with phenotypic BrS, median age 
at first presentation, and follow-up duration were similar in the 2 groups (Table). 
All patients with ≥1 type-1 fever-ECG were carriers of a (likely) pathogenic SCN5A 
variant (13 [2.3%]) or had a 50% likelihood of being a carrier (1 [7.1%]). This ge-
netic background differed significantly from the group without type-1 fever-ECG 
(P<0.001), where 31 patients (37.3%) were carriers of a (likely) pathogenic SCN5A 
variant and 38 (45.8%) were from a genotype-elusive family (Table). In the child 
with ≥1 type-1 fever-ECG and a 50% likelihood of being a carrier, no genetic di-
agnostic testing had been performed. His father was diagnosed with BrS after an 
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aborted cardiac arrest at age 31 and was found to carry 
a SCN5A variant of unknown significance/likely patho-
genic variant.
In this cohort only 1 child had an episode of ventricu-
lar arrhythmia, namely nonsustained ventricular tachy-
cardia during fever. He had ≥1 type-1 fever-ECG and 
carried a SCN5A mutation. No patients in this cohort 
were symptomatic.
We show that, with the exception of 1 child who 
had not yet been tested for the familial variant, only 
pediatric patients from BrS-families with a SCN5A mu-
tation developed a type-1 ECG during fever. The oc-
currence of symptoms in this population was low. The 
molecular and cellular mechanisms underlying the fe-
ver-dependent manifestations of BrS are complex. Fe-
ver may augment dysfunction of the mutated sodium 
cardiac channels, which could lead to an increased sus-
ceptibility to develop a type-1 ECG and arrhythmias.4 
The group without type-1 fever-ECG was genetically 
heterogeneous. According to our study results, a BrS-
phenotype without a SCN5A-mutation seems to be 
absent or concealed during childhood and fever. This 
apparent difference in genetic background in children 
with BrS compared with adults is in agreement with 
recent large cohort studies, in which the proportion of 
SCN5A mutation carriers in young patients appears to 
be higher compared with adults (62% to 77% versus 
23% to 27%).3,5
This study describes a relatively large cohort of pe-
diatric patients from BrS families with numerous fe-
ver- and nonfever-ECGs. Limitations are the heteroge-
neous cohort and retrospective study design, which are 
inevitable in studying this disease. Sensitivity analyses 
including only those patients with a first-degree family 
member with a clear BrS phenotype did not change our 
results.
We conclude that, if future cohort studies sup-
port our findings, recording of fever-ECGs may not 
be mandatory in pediatric patients from BrS families 
without a SCN5A-mutation because their risk for a 
fever-induced Brugada type-1 ECG and arrhythmic 
events is low. A drug challenge, preferably after pu-
berty, can finally make or reject a diagnosis of BrS in 
these children.
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Table. Baseline Characteristics
F-type-1pos (n=14) F-type-1neg (n=83) Complete Cohort (n=97)  P Value
Sex, No. of males (%) 11 (78.6) 43 (51.8) 54 (55.7) 0.08
Median age at first presentation in years (IQR) 4.4 [1.3-6.3] 3.7 [0.8-6.9] 4.0 [0.9-6.8] 0.86
Median follow-up duration in months (IQR) 39 [12-95] 25 [4-41] 27 [4-43] 0.14
First-degree family member with BrS phenotype, n (%) 12 (85.7) 66 (79.5) 78 (80.4) 0.74
Family history of sudden cardiac death, n (%) 5 (35.7) 23 (27.7) 28 (28.9) 0.54
Genotype
 (Likely) pathogenic SCN5A variant, n (%) 13 (92.9) 31 (37.3) 44 (45.4) <0.01
  First-degree family member with (likely) pathogenic 
SCN5A variant, n (%)
1 (7.1) 6 (7.2) 7 (7.2)
 Unknown, n (%) — 1 (1.2) 1 (1.0)
  First-degree family member variant of unknown 
significance, n (%)
— 7 (8.4) 7 (7.2)
 Genotype elusive, n (%) — 38 (45.8) 38 (39.2)
BrS indicates Brugada syndrome; F-type-1pos, ≥1 type-1 fever-ECG; F-type-1neg, without type-1 fever-ECG; and IQR, interquartile range.
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